Product Information
FANAPT 8 MG TABLET is a brand product labeled by Vanda Pharmaceuticals Inc., priced at $37.4823 per EA under NDC 43068010802. Its NADAC has been published 551 times since Feb 24, 2016.
FDA first approved this application on May 6, 2009.
Strength
8 mg/1
Manufacturer
Vanda Pharmaceuticals Inc.NDC
43068010802
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ILOPERIDONEApproval Type
New Drug (NDA)
FDA Application
NDA022192FDA Approved
5/6/2009
On Market Since
9/15/2015
Pharmacological Classes
Price Statistics
The NADAC for FANAPT 8 MG TABLET has been published 551 times since Feb 24, 2016, and over the history we have for it it has risen 106.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $37.4823 per EA |
|---|---|
| All-time high | $37.5270 (Sep 16, 2026) |
| All-time low | $18.1536 (Feb 24, 2016) |
| 52-week high | $37.5270 |
| 52-week low | $36.0183 |
| Median price | $29.4044 |
| Average price | $28.5370 |
| Largest weekly change | +9.0% (Sep 23, 2020) |
| Weeks tracked | 551 |
| Tracking since | Feb 24, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ILOPERIDONE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Vanda Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ILOPERIDONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FANAPT 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FANAPT 8 MG TABLET, manufactured by Vanda Pharmaceuticals Inc., is $37.4823 per EA (NDC 43068010802), effective Sep 30, 2026.
How has the price of FANAPT 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for FANAPT 8 MG TABLET has risen 106.5%. It has been tracked across 551 weekly CMS publications since Feb 24, 2016.
What are the highest and lowest recorded NADAC prices for FANAPT 8 MG TABLET?
Since Feb 24, 2016, the NADAC for FANAPT 8 MG TABLET has ranged from a low of $18.1536 (Feb 24, 2016) to a high of $37.5270 (Sep 16, 2026), with a median of $29.4044 per EA.
Are there cheaper alternatives to FANAPT 8 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FANAPT 8 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FANAPT 8 MG TABLET?
FANAPT 8 MG TABLET (NDC 43068010802) is labeled by Vanda Pharmaceuticals Inc., and CMS classifies it as a brand product.